Bioneer presents its new R&D programs 2021-2024 Starting 2021, Bioneer has initiated two very exciting and ambitious R&D programs that during the next four years will strengthen our capabilities and service solutions that we offer to life science companies. We look forward to seeing our R&D organization move these programs forward and be [...]

Advanced hiPSC-derived in vitro models in toxicology – actiTOX webinar, May 25, 2021 Bioneer is glad to participate to the next talk of the actiTOX webinar series: “Advanced Organotypic Models for Toxicological Screening” on May 25th. The next talk of the actiTOX webinar series will be presented by Dr. Mikkel Rasmussen from Bioneer on May 25th at [...]

Pitfalls and best practices for CRISPR/Cas9-based gene editing webinar, May 25, 2021 Bioneer is looking forward to hosting a LIVE webinar with Samplix on May 25th, on pitfalls and best practices for CRISPR/Cas9-based gene editing.  The webinar has 2 presentations on the agenda, by Dr. Benjamin Schmid from Bioneer and Dr. Peter Mouritzen [...]